Breakthrough: Melaleuca Alternifolia produced in a form safe for human internal use

The ground- breaking discovery by Professor Max Reynolds of the method for removing potential toxicity from Melaleuca Alternifolia, concentrating & distilling the remaining compounds, resulting in a form of Melaleuca that is safe for human internal usehas opened the way to research for new treatments against some of mankind’s most problematic health issues, including:

  • Influenza
  • Dengue fever
  • TB – especially Multi-Drug Resistant Tuberculosis
  • Specific cancers
  • HIV

This form of Melaleuca is called Melaleuca Alternifolia Concentrate (MAC) – brand name: 98alive™

About MAC/ 98alive™

MAC/98alive™ is a PCT global patented, pure extract of Melaleuca Alternifolia (tea tree) oil which contains a unique combination of ninety-eight compounds. Extensive independent human clinical trials from around the world have proven it to be ‘literally non-toxic‘ as reported by Professor Hakim Lukman of Gadjah Mada University, Indonesia’s (qualified at an Australian University) globally recognized and most senior Toxicologist.

The natural compounds are active and may act individually or in combination with other linked compounds to prevent and treat diseases resulting in improved health and general wellbeing.

Internationally, other governmental authorities are using MAC/98alive™ in large scale clinical trials for a wide range of treatments.

MAC/98alive™ is available in capsule form, syrup, nasal spray, throat spray, and in water soluble form to use in inhalation nebulisers. The liquid form is also used in natural oil for topical applications.


Independent testing laboratories around the world have MAC/98alive™ to exhibit:

  • No side effects
  • 14 times greater anti-oxidant reactivity than fish oil and 5 times more than krill oil
  • Immune system boosting properties
  • Anti-viral properties
  • Anti-bacterial properties
  • Anti-fungal properties
  • Anti-mould properties
  • Anti-inflammatory properties to reduce pain and irritation against bruising and soft tissue injury
  • Proven effectiveness against multi-drug resistant microbial, such as MRSA and Multi-Drug Resistant Tuberculosis in individual patients (refer to validations)

Other product specific features will be expanded as clinical trials are completed and the relevant therapeutic values are proven.


At present, MAC/98alive™ is available as an over the counter drug for the following applications:

  • Immune System Strengthener – 150mg capsules
  • Flu & Cold Treatment – 150mg capsules
  • Pain Relief oil – Topical application

However, there are many more potential applications in various stages of research and development. When these tests prove beneficial and are approved by the regulatory authorities, these applications will be made available. The following tables provide an overview of the applications currently under development:

General applications
Table 1

Treatment Capsule 150 mg Oil
 (as required)
Capsule 350 mg Syrup
(for children)
Nasal Spray (1 ml) Throat Spray (2 ml) Nebulizer Solution (3ml) Injection
(5 ml)
Immune Boost Y Y Y Y Y Y Y Y
Antioxidant Y Y Y Y Y Y Y Y
Anti- inflammatory Y Y Y Y Y Y Y Y

Common ailments
Table II

Treatment Capsule 150 mg Oil (as required) Patch
 (as required)
 (as required)
Cream (
as require)
(as require)
Joint pain Y Y Y      
Foot fungus Y Y     Y  
Acne treatment Y       Y  
Scalp treatment Y Y     Y  
Gum/teeth disease Y Y   Y Y  
Ear infections   Y   Y Y  
Sunburn         Y  
Wound treatment Y Y Y   Y  
Vaginal & anal infections Y       Y Y
Herpes 1 & 2 (including cold sores) Y Y Y   Y Y

Major Disease
Table III

Treatment Capsule 150 mg Oil (as required) Syrup (for children) Nasal Spray (1 ml) Throat Spray (2ml) Nebulizer Solution (3ml) Injection (5ml)
Swine flu Y   Y Y Y Y Y
Avian flu Y   Y Y Y Y Y
Dengue fever prevention & treatment Y   Y        
HIV treatment Y   Y       Y
Tuberculosis     Y     Y Y
Lung cancer Y   Y     Y Y
Breast cancer Y Y     Y Y Y

SAFETY: Non-toxic

From a toxicology point of view MAC/98alive™ has been shown to be safe for humans both as a topical application and oral ingestion.

Tests were undertaken on acute, sub-acute, 30 day & 90 day oral ingestion studies (up to 30mg/kg body weight = to 1800 mg/60kg body weight person).

Also, Phase I clinical trial of MAC/ 98alive™ was conducted with 40 volunteers. This trial was to assess any changes to normal body functions with varying dose regimes. Extensive blood and urine analysis was carried out and all were found to be within normal standard levels, even at elevated dosing (up to 900mg/day). Included with this work is a complete pharmacokinetic study.

Three studies were undertaken in 2005 by independent laboratories showed:

  1. Melaleuca Alternifolia oil is non-clastogenic (not mutagenic) in the mouse micronucleus test at dose levels of between 1000mg/kg & 1750 mg/kg.
  2. Melaleuca Alternifolia oil and its major constituent terpinene-4-ol were found not to be mutagens nor carcinogens using the Salmonella reverse mutation assay technique.
  3. MAC/98alive™ was tested at concentrations of between 5-25% for acute dermal toxicity in guinea pigs. There were no ill effects shown.